Clinical trial
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291135 · Carol Fabian, MD, Other · Completed
Key facts
| NCT number | NCT00291135 |
|---|---|
| Title | Protocol for Women at Increased Risk of Developing Breast Cancer |
| Official title | Study of the Effect of Letrozole on Breast Biomarkers of High Risk Postmenopausal Women Receiving Hormone Replacement Therapy |
| Lead sponsor | Carol Fabian, MD, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | letrozole |
| Enrollment | 42 |
| Start date | Jan 1, 2003 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 13, 2006 |
| Last update posted | Jun 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: